Professor, Internal Medicine, Mayo Medical School
Gastroenterology
Dr. Sunanda V. Kane, MD
|
|
Give Review
Sunanda Kane is an expert in the field of Gastroenterology. He graduated from Rush Medical College. He received awards:"Regional Top Doctor", "Fellow (AGAF)" and "Fellow (FACG)". Doctor Sunanda V. Kane, MD is a published doctor and has 99 publications published. The lastest was: 'The menstrual cycle and its effect on inflammatory bowel disease and irritable bowel syndrome: a prevalence study.' He accepts Medicare.
Publications
- Monitoring for Extra-Intestinal Cancers in IBD.
- The Toronto Consensus Guidelines for Nonhospitalized Ulcerative Colitis: A Welcome Update but Not the End of the Story.
- Predictors of Health-Related Quality of Life and Adherence in Crohn's Disease and Ulcerative Colitis: Implications for Clinical Management.
- Validation of a Multidisciplinary Infrastructure to Capture Adverse Events in a High-Volume Endoscopy Unit.
- The use of biologic agents in pregnancy and breastfeeding.
- Anti-tumor necrosis factor agents reduce corticosteroid use compared with azathioprine in patients with Crohn's Disease.
- Inflammatory bowel Disease in women of reproductive age.
- Validation of a CT-Derived Method for Osteoporosis Screening in IBD Patients Undergoing Contrast-Enhanced CT Enterography.
- The role of diagnostic colonoscopy in constipation: a quality improvement project.
- Letter: effectiveness of split-dose certolizumab pegol for Crohn's Disease.
- Inflammatory bowel Disease, women, and pregnancy.
- Cytomegalovirus infection of the ileoanal pouch: clinical characteristics and outcomes.
- IBD: Activity of IBD during pregnancy.
- Inflammatory Bowel Disease is Associated with an Increased Risk of Melanoma: A Systematic Review and Meta-Analysis.
- Hepatitis B Vaccine in IBD.
- Neurologic complications in patients with inflammatory bowel Disease: increasing relevance in the era of biologics.
- Anti-tumor necrosis factor agents and placental transfer: relevant clinical data for rational decision-making.
- "Doctor, I Just Can't": Nonadherence to Surveillance Colonoscopy.
- Impact of MMX® mesalamine on improvement and maintenance of health-related quality of life in patients with Ulcerative colitis.
- Quality commitment: the newly established American College of Gastroenterology Quality Council to meet the needs of clinical gastroenterology.
- Validation of the ulcerative colitis colonoscopic index of severity and its correlation with Disease activity measures.
- Establishing an inflammatory bowel Disease practice in an accountable world.
- What physicians don't know about patient dietary beliefs and behavior can make a difference.
- Familial adenomatous polyposis, suspected HNPCC, and Crohn's Disease: Two cases.
- Response to trindade et Al.
- Strategies in maintenance for patients receiving long-term therapy (SIMPLE): a study of MMX mesalamine for the long-term maintenance of quiescent Ulcerative colitis.
- Natalizumab for moderate to severe Crohn's Disease in clinical practice: The Mayo Clinic Rochester experience.
- Once-Daily Dosing vs. Conventional Dosing Schedule of Mesalamine and Relapse of Quiescent Ulcerative Colitis: Systematic Review and Meta-Analysis.
- Twelve-Month Persistency with Oral 5-Aminosalicylic Acid Therapy for Ulcerative Colitis: Results from a Large Pharmacy Prescriptions Database.
- Meckel's ileitis: Not all regional enteritis is Crohn's Disease.
- Measurement of Disease activity in ulcerative colitis: Interobserver agreement and predictors of severity.
- Current Strategies in the Management of Intra-Abdominal Abscesses in Crohn's Disease.
- Searching for the delta: 5-aminosalicylic Acid therapy for Crohn's Disease.
- Efficacy of 5-aminosalicylates in Crohn's disease: Systematic review and meta-analysis.
- Efficacy of 5-aminosalicylates in ulcerative colitis: Systematic review and meta-analysis.
- Adalimumab for Crohn's Disease in clinical practice at Mayo clinic: the first 118 patients.
- Clinical utility of measuring infliximab and human anti-chimeric antibody concentrations in patients with inflammatory bowel Disease.
- Mentoring in gastroenterology.
- The impact of ulcerative colitis on patients' lives compared to other chronic Diseases: a patient survey.
- Adherence to infliximab maintenance therapy and health care utilization and costs by Crohn's Disease patients.
- Open-label study of adalimumab in patients with Ulcerative colitis including those with prior loss of response or intolerance to infliximab.
- Impact of Ulcerative colitis from patients' and physicians' perspectives: Results from the UC: NORMAL survey.
- Sexual and reproductive issues for men with inflammatory bowel Disease.
- Placental transport of immunoglobulins: a clinical review for gastroenterologists who prescribe therapeutic monoclonal antibodies to women during conception and pregna...
- Cost-effectiveness of 5-aminosalicylic acid therapy for maintenance of remission in Ulcerative colitis.
- Disease perceptions among people with Crohn's Disease.
- Relapses of inflammatory bowel Disease during pregnancy: in-hospital management and birth outcomes.
- Hormonal replacement therapy after menopause is protective of Disease activity in women with inflammatory bowel Disease.
- The challenge of compliance and persistence: focus on Ulcerative colitis.
- Overcoming adherence issues in Ulcerative colitis.
- Assessment of reliability and validity of IBD phenotyping within the National Institutes of Diabetes and Digestive and Kidney Diseases (NIDDK) IBD Genetics Consortium ...
- The effect of a nonabsorbed oral antibiotic (rifaximin) on the symptoms of the irritable bowel Syndrome: a randomized trial.
- Inflammatory bowel Disease characteristics among African Americans, Hispanics, and non-Hispanic Whites: characterization of a large North American cohort.
- Factitious diarrhea masquerading as refractory celiac Disease.
- Epithelial myosin light chain kinase expression and activity are upregulated in inflammatory bowel Disease.
- Tobacco use is associated with accelerated clinical recurrence of Crohn's Disease after surgically induced remission.
- Crohn's is not a 6-week Disease: lifelong management of mild to moderate Crohn's Disease.
- Maintaining remissions across the lifespan: a roundtable discussion with Crohn's Disease experts.
- IBD and Pregnancy.
- Defining complex contributions of NOD2/CARD15 gene mutations, age at onset, and tobacco use on Crohn's Disease phenotypes.
- Fecal lactoferrin is a sensitive and specific marker in identifying Intestinal inflammation.
- Crohn's Disease involving the gallbladder. case report and review of the literature.
- The efficacy of oral 5-ASAs in the treatment of active ulcerative colitis: a Systematic review.
- Current approaches to the management of new-onset Ulcerative colitis.
- Adalimumab for the treatment of inflammatory bowel Disease.
- An evidence-based Systematic review on medical therapies for inflammatory bowel disease.
- IBD: measuring what counts-safety of IBD medications in pregnancy.
- Gender-related issues in the female inflammatory bowel Disease patient.
- Current and future therapies for inflammatory bowel Disease.
- Strategies to improve adherence and outcomes in patients with Ulcerative colitis.
- Refined genomic localization and ethnic differences observed for the IBD5 association with Crohn''s Disease.
- Novel therapies in the treatment of Ulcerative colitis.
- Absence of infliximab in infants and breast milk from nursing mothers receiving therapy for Crohn's Disease before and after delivery.
- The menstrual cycle and its effect on inflammatory bowel Disease and irritable bowel syndrome: a prevalence study.
- Colon Cancer surveillance in chronic ulcerative colitis: historical cohort study.
- HLA disparity determines Disease activity through pregnancy in women with inflammatory bowel Disease.
- Higher incidence of abnormal Pap smears in women with inflammatory bowel Disease.
- An open-label study of the human anti-TNF monoclonal antibody adalimumab in subjects with prior loss of response or intolerance to infliximab for Crohn's Disease.
- The use of medications for inflammatory bowel Disease during pregnancy and nursing.
- Systematic review: short-term adverse effects of 5-aminosalicylic acid agents in the treatment of ulcerative colitis.
- The effectiveness of budesonide therapy for Crohn''s Disease.
- Once-daily dosing of delayed-release oral mesalamine (400-mg tablet) is as effective as twice-daily dosing for maintenance of remission of Ulcerative colitis.
- Predictors of persistence with 5-aminosalicylic acid therapy for Ulcerative colitis.
- Pregnancy outcomes in women with inflammatory bowel Disease: a large community-based study from Northern California.
- Prevalence of nonadherence with maintenance mesalamine in quiescent Ulcerative colitis.
- Intentional infliximab use during pregnancy for induction or maintenance of remission in Crohn''s Disease.
- Thalidomide therapy for patients with refractory Crohn's Disease: an open-label trial.
- Systematic review: impact of non-adherence to 5-aminosalicylic acid products on the frequency and cost of ulcerative colitis flares.
- Medication non-adherence is associated with increased medical health care costs.
- A pilot feasibility study of once daily versus conventional dosing mesalamine for maintenance of Ulcerative colitis.
- The role of breastfeeding in postpartum Disease activity in women with inflammatory bowel Disease.
- Use of a screening tool to determine nonadherent behavior in inflammatory bowel Disease.
- Abnormal Pap smears in inflammatory bowel Disease.
- Controversies in mucosal healing in Ulcerative colitis.
- Medication nonadherence and the outcomes of patients with quiescent Ulcerative colitis.
- Effect of folate supplementation on the incidence of dysplasia and Cancer in chronic ulcerative colitis. A case-control study.
- Lack of association between oral contraceptive use and Crohn's Disease: a community-based matched case-control study.
- Lack of association between oral contraceptive use and Ulcerative colitis.
Schools
Rush Medical College Of Rush University
Rush Presbyn St Lukes Mc
University of Chicago
Procedures Preformed
- Colonoscopy, Proctosigmoidoscopy, and Sigmoidoscopy
- Endoscopy (Esophagus, Stomach, Small Intestine)
- Manometry
Conditions Treated
- Abdominal Pain
- Anemia
- Barrett's Esophagus
- Benign Neoplasm of the Digestive System
- View All
Doctors Specialties
- Gastroenterology
Accepted Insurances
- Choice Plus POS II
- Blue Card PPO
- Blue Cross Blue Shield of Illinois PPO
- Blue Cross Accord
- Cigna PPO
- Great West Healthcare-Cigna PPO
- Open Access Plus
- MultiPlan PPO
- PHCS Network PPO
- Choice Plus POS
- Navigate POS
- Options PPO
Awards
- Regional Top Doctor
- Fellow (AGAF)
- Fellow (FACG)
Education
-
University of Chicago -
Rush University Medical Center -
Rush Medical College
Hospital
-
Mayo Clinic - Rochester, Minnesota
Drug Facts
| NPI NUMBER | 1801957634 | |
| NPPES Provider LastName | KANE | |
| NPPES Provider FirstName | SUNANDA | |
| NPPES Provider ZIPCode | 559050001 | |
| NPPES Provider State | MN | |
| Specialty Description | Gastroenterology | |
| Total Claim Count | 228.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1801957634 |
| Last Name Of The Provider | KANE |
| First Name Of The Provider | SUNANDA |
| View All |
Similar Doctors
|
|
Dr. Karthik Ravi, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. David A. Ahlquist, MD |
|
|
Dr. Albert J. Czaja, MD
This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. Sara M. Echelmeyer, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Navtej S. Buttar, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Shounak Majumder, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Shamina Dhillon, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Todd H. Baron, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Rajeswari Anaparthy, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Behnam Saberi, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Jason S. Puckett, MD
This Doctor is OpenDoctor Recommended.
|